CIK 0000105770 · Large accelerated filer
WEST PHARMACEUTICAL SERVICES INC
Sign in to watch- Ticker
- WST
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- PA
- Entity type
- operating
- EIN
- 231210010
- Phone
- 6105942900
- Business address
- 530 HERMAN O. WEST DRIVE, EXTON, PA, 19341
- Former names
- WEST CO INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,443,749
- in 2 filings, $2.7M under 10b5-1 plans
Net −$5,443,749. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-06 | BUTHMAN MARK A Director | Grant or award | +1,071 | 42,860.93 | ||
| 2025-03-31 | HAUGEN JANET BRUTSCHEA Director | Grant or award · Phantom Stock Unit | +56 | $223.88 | $13K | 56 |
| 2025-02-18 | Birkett Bernard Sr VP, Chief Financial Officer | Option exercise | +779.35 | $211.00 | $164K | 7,668.77 |
| 2025-02-18 | Birkett Bernard Sr VP, Chief Financial Officer | Shares withheld for taxes | −237.76 | $211.00 | $50K | 7,431.01 |
| 2025-02-18 | Birkett Bernard Sr VP, Chief Financial Officer | Option exercise | +124.98 | $211.00 | $26K | 7,555.99 |
| 2025-02-18 | Birkett Bernard Sr VP, Chief Financial Officer | Shares withheld for taxes | −35.61 | $211.00 | $8K | 7,520.38 |
| 2025-02-18 | Birkett Bernard Sr VP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +4,020 | 4,020 | ||
| 2025-02-18 | Birkett Bernard Sr VP, Chief Financial Officer | Grant or award · Rst. Stock Unit | +1,740 | 1,740 | ||
| 2025-02-18 | Reiss-Clark Cindy Chief Commercial Officer | Option exercise | +246.16 | $211.00 | $52K | 5,130.51 |
| 2025-02-18 | Reiss-Clark Cindy Chief Commercial Officer | Shares withheld for taxes | −83.18 | $211.00 | $18K | 5,047.33 |
| 2025-02-18 | Reiss-Clark Cindy Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +1,162 | 1,162 | ||
| 2025-02-18 | Reiss-Clark Cindy Chief Commercial Officer | Grant or award · Rst. Stock Unit | +503 | 503 | ||
| 2025-02-18 | MacKay Kimberly Banks SVP, GC & Corporate Secretary | Option exercise | +246.16 | $211.00 | $52K | 1,604.63 |
| 2025-02-18 | MacKay Kimberly Banks SVP, GC & Corporate Secretary | Shares withheld for taxes | −92.69 | $211.00 | $20K | 1,511.93 |
| 2025-02-18 | MacKay Kimberly Banks SVP, GC & Corporate Secretary | Grant or award · Stock Option (Right to Buy) | +1,162 | 1,162 | ||
| 2025-02-18 | MacKay Kimberly Banks SVP, GC & Corporate Secretary | Grant or award · Rst. Stock Unit | +503 | 503 | ||
| 2025-02-18 | Favorite Annette F Sr. VP & Chief HR Officer | Option exercise | +246.16 | $211.00 | $52K | 6,822.53 |
| 2025-02-18 | Favorite Annette F Sr. VP & Chief HR Officer | Shares withheld for taxes | −83.79 | $211.00 | $18K | 6,738.74 |
| 2025-02-18 | Favorite Annette F Sr. VP & Chief HR Officer | Grant or award · Stock Option (Right to Buy) | +1,251 | 1,251 | ||
| 2025-02-18 | Favorite Annette F Sr. VP & Chief HR Officer | Grant or award · Rst. Stock Unit | +542 | 542 |
Page 7 of 13 · 257 trades